Ferring Pharmaceuticals

This study looked at the safety of the drug NOCDURNA, which is used to treat adults who wake up frequently at night to urinate. Researchers reviewed existing medical records from over a million people in Denmark, Sweden, and Germany to check for serious side effects, especially r…

This study tested the safety and effectiveness of a treatment called RBX2660 (REBYOTA®) when given during a colonoscopy. It involved 41 adults suffering from recurrent C. difficile infections, a serious and debilitating gut condition. The goal was to see if this new delivery meth…

This study compared two different fertility medications to help women undergoing IVF produce more eggs. Researchers tested whether a newer drug (follitropin delta) worked as well as a commonly used one (Gonal-F) when given at different starting doses. The goal was to find the mos…

This study followed 57 men with prostate cancer to check the long-term safety of a medication called degarelix. It was an extension of a previous trial, and patients received treatment for at least five years. The main goal was to monitor for any concerning changes in health, lik…

This study observed 145 adult patients who received REBYOTA, a treatment designed to prevent repeat C. difficile infections. Researchers tracked patients for 6 months after treatment to see if the infection returned and to monitor their health. The main goal was to see how many p…

This study observed how a fertility drug called REKOVELLE® was used in everyday medical practice for women undergoing their first IVF treatment. Researchers tracked 201 women to see how doctors decided on doses, monitored safety, and what pregnancy outcomes resulted. The goal was…